PYDOXAL Side Effects

6163999-1 | Acute Hepatic Failure, Leukocytosis, Thrombocytopenia
on Apr 09, 2009 Male patient from JAPAN , weighting 116.0 lb, was diagnosed with tuberculosis (What is tuberculosis?), insomnia, angina pectoris, hyperparathyroidism secondary, hyperphosphataemia, hypothyroidism and was treated with Pydoxal (View Usage). Patient experienced the following unwanted or unexpected effects: acute hepatic failure, leukocytosis, thrombocytopenia. Pydoxal dosage: . During the same period patient was treated with NEOISCOTIN (View Neoiscotin Review and Neoiscotin Label ), LENDORMIN D (View Lendormin D Review and Lendormin D Label ), MYSLEE (View Myslee Review and Myslee Label ), BUFFERIN (View Bufferin Review and Bufferin Label ), CALTAN (View Caltan Review and Caltan Label ), THYRADIN S (View Thyradin-s Review and Thyradin-s Label ), PLAVIX (View Plavix Review and Plavix Label ).

6077747-7 | Acute Hepatic Failure
Patient was taking Pydoxal (View Usage). Patient had the following side effects: acute hepatic failure on Feb 03, 2009 from JAPAN Additional patient health information: Male patient , weighting 116.0 lb, was diagnosed with tuberculosis (What is tuberculosis?), insomnia, hyperlipidaemia, angina pectoris, peripheral circulatory failure, hyperparathyroidism secondary and. Pydoxal dosage: . During the same period patient was treated with NEOISCOTIN (View Neoiscotin Review and Neoiscotin Label ), LENDORMIN D (View Lendormin D Review and Lendormin D Label ), MYSLEE (View Myslee Review and Myslee Label ), ZETIA (View Zetia Review and Zetia Label ), SIGMART (View Sigmart Review and Sigmart Label ), ANPLAG (View Anplag Review and Anplag Label ), BUFFERIN (View Bufferin Review and Bufferin Label ), CALTAN (View Caltan Review and Caltan Label ).

5821640-9 | Palmar-plantar Erythrodysaesthesia Syndrome
Adverse event was reported on Jul 18, 2008 by a Male patient taking Pydoxal (View Usage) (Dosage: Unk) . Location: JAPAN , weighting 138.7 lb, After Pydoxal was administered, patient had the following side effects: palmar-plantar erythrodysaesthesia syndrome. During the same period patient was treated with PL (Unk) (View Pl Review and Pl Label ), KYTRIL (Unk) (View Kytril Review and Kytril Label ), DEXART (Unk) (View Dexart Review and Dexart Label ), SEROTONE (Unk) (View Serotone Review and Serotone Label ), DECADRON (Unk) (View Decadron Review and Decadron Label ), AVASTIN (View Avastin Review and Avastin Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

5798726-0 | Neutrophil Count Decreased, Rhabdomyolysis
on Jun 23, 2008 Female patient from JAPAN , weighting 110.2 lb, was diagnosed with palmar-plantar erythrodysaesthesia syndrome, colon cancer, gastritis prophylaxis and was treated with Pydoxal (View Usage). Patient experienced the following unwanted or unexpected effects: neutrophil count decreased, rhabdomyolysis. Pydoxal dosage: 10 Mg. During the same period patient was treated with ISOVORIN (View Isovorin Review and Isovorin Label ), KYTRIL (3 Mg) (View Kytril Review and Kytril Label ), FLUOROURACIL (575 Mg/body=399.3 Mg/m2 In Bolus Then 3500 Mg/body=2430.6 Mg/m2 As Continuous Infusion) (View Fluorouracil Review and Fluorouracil Label ), PANTOSIN (View Pantosin Review and Pantosin Label ), ELPLAT (View Elplat Review and Elplat Label ), GASTER (View Gaster Review and Gaster Label ). Patient was hospitalized.